文献速递血液净化与透析

血液透析通路类型与死亡率关联:通路并发症的作用

Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications.
PubMed 文献 · Clin J Am Soc Nephrol · 2017-05-18

该研究基于DOPPS 1996-2011年数据,纳入6119例起始血液透析患者,采用中介分析检验通路并发症是否解释导管或移植血管相对动静脉瘘的更高死亡率。结果显示,调整通路并发症前后,导管对比瘘的死亡风险比几乎相同(HR 2.00 vs 2.01),通路并发症并未中介该关联。

要点

  • 导管或移植血管对比瘘的更高死亡率并非由通路并发症增加所解释。
  • 调整通路并发症前后,导管对比瘘的死亡风险比几乎一致。
  • 需临床试验明确通路类型与死亡的关联是否为因果或混杂。

核心结论

  • 血液透析通路并发症似乎不能解释通路类型与死亡率之间的关联。

研究设计与样本

  • 研究纳入北美、欧洲和澳大拉西亚1996-2011年起始血液透析的6119例成人患者(DOPPS研究)。
  • 采用中介分析检验通路并发症是否中介通路类型与6个月死亡率的关系。

主要发现

  • 随访6个月内,2084例(34%)发生通路非感染性并发症,542例(8.9%)发生感染性并发症,526例(8.6%)死亡。
  • 通路类型预测通路并发症发生,通路类型和并发症均预测死亡率。
  • 排除与纳入通路并发症的模型中,导管对比瘘的死亡风险比几乎相同(HR 2.00,95%CI 1.55-2.58 vs HR 2.01,95%CI 1.56-2.59)。

临床怎么用

  • 临床不应仅以降低通路并发症为理由来解释导管或移植血管使用者的超额死亡风险。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: People receiving hemodialysis to treat kidney failure need a vascular access (a fistula, a graft, or a central venous catheter) to connect to the blood purification machine. Higher rates of access complications are considered the mechanism responsible for the excess mortality observed among catheter or graft users versus fistula users. We tested this hypothesis using mediation analysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We studied incident patients who started hemodialysis therapy from North America, Europe, and Australasia (the Dialysis Outcomes and Practice Patterns Study; 1996-2011). We evaluated the association between access type and time to noninfectious (e.g., thrombosis) and infectious complications of the access (mediator model) and the relationship between access type and time-dependent access complications with 6-month mortality from the creation of the first permanent access (outcome model). In mediation analysis, we formally tested whether access complications explain the association between access type and mortality. RESULTS: Of the 6119 adults that we studied (mean age =64 [SD=15] years old; 58% men; 47% patients with diabetes), 50% had a permanent catheter for vascular access, 37% had a fistula, and 13% had a graft. During the 6-month study follow-up, 2084 participants (34%) developed a noninfectious complication of the access, 542 (8.9%) developed an infectious complication, and 526 (8.6%) died. Access type predicted the occurrence of access complications; both access type and complications predicted mortality. The associations between access type and mortality were nearly identical in models excluding and including access complications (hazard ratio, 2.00; 95% confidence interval, 1.55 to 2.58 versus hazard ratio, 2.01; 95% confidence interval, 1.56 to 2.59 for catheter versus fistula, respectively). In mediation analysis, higher mortality with catheters or grafts versus fistulas was not the result of increased rates of access complications. CONCLUSIONS: Hemodialysis access complications do not seem to explain the association between access type and mortality. Clinical trials are needed to clarify whether these associations are causal or reflect confounding by underlying disease severity.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ravani P, Quinn R, Oliver M, et al. Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access Complications. Clin J Am Soc Nephrol. 2017. PMID: 28522650. doi:10.2215/CJN.12181116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。